📢 Company Overview:
Abbott Point of Care Inc. (APOC) is a $600 million division of Abbott Laboratories (NYSE: ABT), headquartered in Princeton, New Jersey. Founded in 1983, the company is a global leader in handheld point-of-care diagnostics, best known for the i-STAT System that provides lab-quality blood analysis results in as little as two minutes at the patient bedside. The company's products are used in hospitals, emergency departments, critical care units, and operating rooms across more than 100 countries worldwide.
Company Profile (Updated April 2026)
Abbott Point of Care Inc. (APOC) is a wholly-owned subsidiary of Abbott Laboratories (NYSE: ABT), operating within Abbott's global Diagnostics business segment. Headquartered in Princeton, New Jersey, the company specializes in the development, manufacturing, and marketing of critical medical diagnostic and data management products for Rapid blood analysis.
APOC's flagship i-STAT System is an advanced, portAble diagnostic platform that provides real-time, lab-quality results within minutes, enabling healthcare professionals to make rapid triage and treatment decisions at the point of care. The system features the industry's most comprehensive menu of tests in a single handheld platform, including blood gases, electrolytes, chemistries, coagulation, hematology, glucose, cardiac markers, and traumatic brain injury (TBI) biomarkers.
Corporate History & Structure
- Founded: June 1983
- Parent Company: Abbott Laboratories (NYSE: ABT) - Global healthcare leader with approximately 114,000 employees serving people in more than 160 countries
- Headquarters: 400 College Road East, Princeton, NJ 08540-6607, United States
- Business Type: Medical Equipment and Supplies Manufacturing
- Employees: 100-249 (per Dun & Bradstreet and corporate records); divisional scale within Abbott's 114,000 global workforce
- Estimated Division Revenue: $600 million (per Abbott corporate disclosures)
Headquarters & Operations
Primary Address:
400 College Road East
Princeton, NJ 08540-6607
United States
Phone: Available through Abbott corporate switchboard
Additional Location (FDA Records):
i-STAT Analyzer manufacturing and regulatory operations registered at Princeton, NJ facility
Leadership Team
Eric Shroff: President, Abbott Point of Care; Senior Vice President, Abbott Laboratories
Key Responsibilities: Oversees global strategy, product development, and commercial operations for Abbott's point-of-care diagnostics portfolio
Core Product Portfolio
i-STAT System
The flagship handheld blood analyzer providing lab-quality results in minutes:
- i-STAT 1 Analyzer: Handheld device used with single-use i-STAT test cartridges; results in as little as two minutes for most tests
- i-STAT Alinity: Enhanced system providing greater flexibility and reliability for point-of-care testing
- Test Cartridge Menu: Comprehensive single-platform menu including:
• Blood gases (pH, pCO2, pO2, TCO2, HCO3, Base Excess, sO2)
• Electrolytes (Sodium, Potassium, Chloride, Ionized Calcium)
• Chemistries (Glucose, BUN, Creatinine, Lactate)
• Coagulation (ACT Celite, ACT Kaolin)
• Hematology (Hematocrit, Hemoglobin)
• Cardiac markers (cTnI, CK-MB, BNP)
• Traumatic Brain Injury (TBI) biomarkers
- Wireless Connectivity: i-STAT Wireless enables automatic transmission of test results; cartridges are downloaded when the handheld is placed in a downloader
ID NOW Platform
Rapid molecular testing system for infectious diseases:
- ID NOW Influenza A & B 2.0: Rapid detection of influenza viruses
- ID NOW RSV: Respiratory syncytial virus detection
- ID NOW Strep A: Streptococcus A detection
- ID NOW COVID-19: SARS-CoV-2 molecular test (EUA authorized during pandemic)
Additional Diagnostic Products
- BinaxNOW: Lateral flow rapid diagnostic tests for infectious diseases and cardiac markers
- Panbio: Rapid diagnostic tests for infectious diseases (international markets)
- Alere Toxicology Screen: Quick screening tests for drugs of abuse
Strategic Positioning & Market Presence
Global ReACH: i-STAT System used in hospitals and clinics in more than 100 countries, with particular strength in:
- Critical Care: Emergency departments, intensive care units, and operating rooms
- Outpatient Settings: Urgent care clinics and physician offices
- Cardiovascular Care: Rapid cardiac marker testing for heart attack diagnosis
- Traumatic Brain Injury: i-STAT TBI test for rapid concussion assessment
Clinical Value Proposition:
- Reduces time to treatment decisions by eliminating laboratory transport delays
- Minimizes process steps and handoffs, reducing incidence of errors
- Enables patient-centered care with bedside testing
- Supports collaborative care environments between nurses, physicians, and specialists
Regulatory Compliance
FDA Registration:
- i-STAT System and cartridges registered with FDA as Class II medical devices
- Multiple FDA 510(k) clearances for various test cartridges
- Historical FDA recalls documented for i-STAT Analyzer Model 200 (2010) and various cartridges (CREA, ACT, cTnI, CK-MB, BNP), demonstrating active regulatory oversight and quality monitoring
International Certifications:
- CE marking for European market access
- ISO quality management system compliance
- Regulatory approvals in 100+ countries worldwide
2025-2026 Operational Status
Active Recruitment (2025): Abbott Point of Care maintained active hiring throughout 2025, posting multiple positions based at the Princeton headquarters including:
- Outpatient Marketing Manager, US Marketing
- Director, Medical Affairs (Americas)
- Manager, APOC Service Sales and Operations
Q1 2026 Diagnostics Segment Performance:
- Abbott's worldwide Diagnostics sales increased 6.1% on a reported basis in Q1 2026
- Note: Beginning in 2026, Abbott aggregated its previously reported Rapid Diagnostics, Molecular Diagnostics, and Point of Care businesses into the Rapid and Molecular Diagnostics reporting segment
- The i-STAT System and related point-of-care products continue to be manufactured and distributed globally
Integration with Abbott Diagnostics
As part of Abbott's global Diagnostics segment, Abbott Point of Care benefits from:
- Access to Abbott's global supply chain and distribution networks
- Integration with Alinity and Architect laboratory diagnostic platforms
- Shared regulatory expertise and quality management systems
- Cross-segment synergies with Abbott's Medical Devices and Nutrition businesses
- Investment in next-generation digital health and connected care technologies
Corporate Information
Legal Name: Abbott Point of Care Inc.
- Parent Company: Abbott Laboratories (NYSE: ABT)
- Founded: 1983
- Headquarters: 400 College Road East, Princeton, NJ 08540-6607, USA
- Industry: Health Care Equipment / Medical Devices & Equipment
- Employees: 100-249
- Division Revenue: $600 million (estimated)
- Website: https://www.globalpointofcare.abbott
Contact Information
Abbott Point of Care Inc.
400 College Road East
Princeton, NJ 08540-6607
United States
Parent Company:
Abbott Laboratories
100 Abbott Park Road
Abbott Park, IL 60064
United States
Phone: +1 (224) 668-3222 (Investor Relations)
Web: www.abbott.com
Keywords: Abbott Point of Care, APOC, Abbott Laboratories, Princeton New Jersey, i-STAT System, i-STAT Alinity, point-of-care diagnostics, handheld blood analyzer, ID NOW, rapid diagnostics, POC testing, Eric Shroff, cardiac markers, traumatic brain injury, TBI test, blood gases, electrolytes, coagulation, critical care diagnostics, bedside testing, 400 College Road East, medical devices, globalpointofcare.abbott
